TP53 and cancer: While the interplay between the IGF1 signaling axis and the p53 genome protection pathways has been primarily investigated in the context of cancer cells, new evidence links these converging networks to the regulation of metabolism, including glucose transport, glycolysis, mitochondrial biology, and energy generation.